| Literature DB >> 27830986 |
Kentaro Igarashi1,2,3, Kei Kawaguchi1,2, Tasuku Kiyuna1,2, Takashi Murakami1,2, Shinji Miwa3, Scott D Nelson4, Sarah M Dry4, Yunfeng Li4, Arun Singh5, Hiroaki Kimura3, Katsuhiro Hayashi3, Norio Yamamoto3, Hiroyuki Tsuchiya3, Fritz C Eilber6, Robert M Hoffman1,2.
Abstract
Rhabdomyosarcoma (RMS) is a rare mesenchymal tumor. The aim of the present study was to develop a patient-derived orthotopic xenograft (PDOX) mouse model of RMS and compare the PDOX model to a subcutaneous (s.c.)-transplant model. A patient RMS from a striated muscle was grown orthotopically in the right biceps femoris muscle and right quadriceps muscle of nude mice to establish a PDOX model, as well as under the skin to establish an s.c. MODEL: PDOX tumors grew at a statistically-significant faster rate compared to the s.c. tumors. Recurrence after surgical resection occurred only in PDOX tumors, not in the s.c. MODEL: Histologically, only the PDOX model was shown to be invasive. In conclusion, these results indicate that the PDOX model of adult RMS is malignant and the subcutaneous model is benign. These results emphasize that a proper tumor microenvironment is necessary for patient-like behavior of a tumor in a mouse model.Entities:
Keywords: PDOX; muscle; nude mouse; patient-derived orthotopic xenograft; recurrence; resection; rhabdomyosarcoma; subcutaneous; tumor growth rate
Mesh:
Year: 2016 PMID: 27830986 PMCID: PMC5270546 DOI: 10.1080/15384101.2016.1252885
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534